New to GLP-1 therapy? Read the full guide to medical weight loss in Newport Beach before starting.
A 90-day protocol using GLP-1 medication at doses below the standard weight-loss range. Physician-supervised by Dr. Amir Mortazavi, MD.
"Microdosing" isn't a standardized term — it means different things at different practices, so here is what it means here: tirzepatide administered at doses below those used for conventional weight-loss treatment, over a defined 90-day course.
Who this suits:
Patients wanting modest, gradual change rather than substantial weight loss · patients who tolerated standard dosing poorly and had to stop · patients near their goal weight looking for metabolic support and appetite regulation · patients who want to try GLP-1 therapy at a lower entry point before committing to a full protocol · patients maintaining after a previous course
Who this doesn't suit:
Patients with significant weight to lose. Lower dosing produces proportionally smaller results, and someone with a substantial goal will be disappointed by a protocol that wasn't designed for it. Standard-dose therapy is the appropriate route, and Dr. Mortazavi will say so rather than selling you a lighter version of the wrong thing.
What's included over 90 days: physician consultation and medical history review · prescription and medication for the full course · dose adjustment based on your response · monitoring and side-effect management throughout
Lower dose generally means fewer side effects. Nausea, GI upset, and fatigue are dose-related, and they're the main reason people abandon GLP-1 therapy in the first month. Lower dosing tends to be better tolerated — though it isn't a guarantee, and side effects are managed as they arise.
What to expect over the course. Change with low-dose therapy is gradual. Appetite regulation typically shifts within the first few weeks; physical change follows more slowly. A 90-day course is long enough to see a genuine trend and decide whether to continue, adjust, or stop.
What happens after 90 days is discussed at the end of the course based on your response — continuing at the same dose, increasing, transitioning to standard protocol, or stopping. That's a decision made with results in hand rather than committed to now.
This is prescription medical care. GLP-1 medications affect appetite regulation, gastric emptying, and metabolic signaling, and they aren't appropriate for everyone. Medical history, current medications, and relevant conditions are reviewed before anything is prescribed.
Also worth planning for: meaningful weight loss commonly causes facial volume loss. Even at lower doses over 90 days it's worth knowing about — more on GLP-1 facial volume loss.
New to GLP-1 therapy? Read the full guide to medical weight loss in Newport Beach before starting.
A 90-day protocol using GLP-1 medication at doses below the standard weight-loss range. Physician-supervised by Dr. Amir Mortazavi, MD.
"Microdosing" isn't a standardized term — it means different things at different practices, so here is what it means here: tirzepatide administered at doses below those used for conventional weight-loss treatment, over a defined 90-day course.
Who this suits:
Patients wanting modest, gradual change rather than substantial weight loss · patients who tolerated standard dosing poorly and had to stop · patients near their goal weight looking for metabolic support and appetite regulation · patients who want to try GLP-1 therapy at a lower entry point before committing to a full protocol · patients maintaining after a previous course
Who this doesn't suit:
Patients with significant weight to lose. Lower dosing produces proportionally smaller results, and someone with a substantial goal will be disappointed by a protocol that wasn't designed for it. Standard-dose therapy is the appropriate route, and Dr. Mortazavi will say so rather than selling you a lighter version of the wrong thing.
What's included over 90 days: physician consultation and medical history review · prescription and medication for the full course · dose adjustment based on your response · monitoring and side-effect management throughout
Lower dose generally means fewer side effects. Nausea, GI upset, and fatigue are dose-related, and they're the main reason people abandon GLP-1 therapy in the first month. Lower dosing tends to be better tolerated — though it isn't a guarantee, and side effects are managed as they arise.
What to expect over the course. Change with low-dose therapy is gradual. Appetite regulation typically shifts within the first few weeks; physical change follows more slowly. A 90-day course is long enough to see a genuine trend and decide whether to continue, adjust, or stop.
What happens after 90 days is discussed at the end of the course based on your response — continuing at the same dose, increasing, transitioning to standard protocol, or stopping. That's a decision made with results in hand rather than committed to now.
This is prescription medical care. GLP-1 medications affect appetite regulation, gastric emptying, and metabolic signaling, and they aren't appropriate for everyone. Medical history, current medications, and relevant conditions are reviewed before anything is prescribed.
Also worth planning for: meaningful weight loss commonly causes facial volume loss. Even at lower doses over 90 days it's worth knowing about — more on GLP-1 facial volume loss.
Image 1 of 1
